HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18

Aura Biosciences Inc

Aura Biosciences Inc

AURA

0.00

HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ: AURA) with a Buy and lowers the price target from $24 to $18.